Retinoblastoma management during the COVID-19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries

Affiliations

¹ International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.
² Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.
³ Department of Ophthalmology, University of Washington, Seattle, Washington.
⁴ Ophthalmology Department, Great Ormond Street Children's Hospital, London, UK.
⁵ Sankara Nethralaya, Chennai, India.
⁶ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁷ Department of Ophthalmology, Royal Children's Hospital, Parkville, Victoria, Australia.

Comment

Ido Didi Fabian et al. Pediatr Blood Cancer. 2021 Jan.

. 2021 Jan;68(1):e28584.

doi: 10.1002/pbc.28584. Epub 2020 Aug 6.

¹ International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.
² Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.
³ Department of Ophthalmology, University of Washington, Seattle, Washington.
⁴ Ophthalmology Department, Great Ormond Street Children's Hospital, London, UK.
⁵ Sankara Nethralaya, Chennai, India.
⁶ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁷ Department of Ophthalmology, Royal Children's Hospital, Parkville, Victoria, Australia.

No abstract available

Conflict of interest statement

We declare no competing interests relevant to the present work.

Global Retinoblastoma Presentation and Analysis by National Income Level.
Global Retinoblastoma Study Group; Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, Ahmad A, Akib MNR, Al Harby L, Al Ani MH, Alakbarova A, Portabella SA, Al-Badri SAF, Alcasabas APA, Al-Dahmash SA, Alejos A, Alemany-Rubio E, Alfa Bio AI, Alfonso Carreras Y, Al-Haddad C, Al-Hussaini HHY, Ali AM, Alia DB, Al-Jadiry MF, Al-Jumaily U, Alkatan HM, All-Eriksson C, Al-Mafrachi AARM, Almeida AA, Alsawidi KM, Al-Shaheen AASM, Al-Shammary EH, Amiruddin PO, Antonino R, Astbury NJ, Atalay HT, Atchaneeyasakul LO, Atsiaya R, Attaseth T, Aung TH, Ayala S, Baizakova B, Balaguer J, Balayeva R, Balwierz W, Barranco H, Bascaran C, Beck Popovic M, Benavides R, Benmiloud S, Bennani Guebessi N, Berete RC, Berry JL, Bhaduri A, Bhat S, Biddulph SJ, Biewald EM, Bobrova N, Boehme M, Boldt HC, Bonanomi MTBC, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brennan RC, Brichard BG, Buaboonnam J, Calderón-Sotelo P, Calle Jara DA, Camuglia JE, Cano MR, Capra M, Cassoux N, Castela G, Castillo L, Català-Mora J, Chantada GL, Chaudhry S, Chaugule SS, Chauhan A, Chawla B, Chernodrinska VS, Chiwanga FS, Chuluunbat T, Cieslik K, Cockcr… See abstract for full author list ➔ Global Retinoblastoma Study Group, et al. JAMA Oncol. 2020 May 1;6(5):685-695. doi: 10.1001/jamaoncol.2019.6716. JAMA Oncol. 2020. PMID: 32105305 Free PMC article.

1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:P497‐506. - PMC - PubMed
1. World Health Organization . WHO Director General's opening remarks at the media briefing on COVID‐19, March 11, 2020. [Internet]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re... [Accessed April 1, 2020].
1. The Lancet Oncology . COVID‐19: global consequences for oncology. Lancet Oncol. 2020;21:467. - PMC - PubMed
1. Bouffet E, Challinor J, Sullivan M, Biondi A, Rodriguez‐Galindo C, Pritchard‐Jones K. Early advice on managing children with cancer during the COVID‐19 pandemic and a call for sharing experiences. Pediatr Blood Cancer;n/a:e28327. https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.28327. - DOI - PubMed
1. Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129‐1131. - PubMed